These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15688624)

  • 1. High dose chemotherapy and hematopoietic progenitor cell transplantation for breast cancer.
    Pedrazzoli P; Tarenzi E; Tullio C; Colosini G; Siena S
    J Chemother; 2004 Nov; 16 Suppl 4():108-11. PubMed ID: 15688624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means].
    Sola Rocabert C; Mesía R; Mendoza L; Tabernero JM; Amill B; Maroto P; Bellet M; Ojeda B; Alonso MC; Verger G
    Med Clin (Barc); 1995 Oct; 105(11):407-11. PubMed ID: 7475451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy].
    Derigs HG; Huber C; Mahlke M; Kolbe K
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):190-7. PubMed ID: 8682284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.
    Pedrazzoli P; Martino M; Delfanti S; Generali D; Rosti G; Bregni M; Lanza F;
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):70-5. PubMed ID: 26063892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy and stem cell transplantation does not improve relapse-free or overall survival in women with high-risk breast cancer.
    Carlson RW; Wheatley K
    Cancer Treat Rev; 2004 Feb; 30(1):131-7. PubMed ID: 14766131
    [No Abstract]   [Full Text] [Related]  

  • 6. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 7. Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.
    Martino M; Bottini A; Rosti G; Generali D; Secondino S; Barni S; Maisano R; Lanza F; Castagna L; Pedrazzoli P
    Expert Opin Biol Ther; 2012 Nov; 12(11):1505-15. PubMed ID: 22946512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
    Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
    N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma].
    Kier P; Ruckser R; Buxhofer V; Habertheuer KH; Zelenka P; Tatzreiter G; Hübl G; Kittl E; Hauser A; Sebesta C; Hinterberger W
    Acta Med Austriaca Suppl; 2000; 52():33-6. PubMed ID: 11261276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma].
    Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M
    Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].
    Mukaiyama T; Okamoto R; Sasaki T
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1731-40. PubMed ID: 7574803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
    Shi Y; Pan F; Han X
    Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.
    Pedrazzoli P; Martinelli G; Gianni AM; Da Prada GA; Ballestrero A; Rosti G; Frassineti GL; Aieta M; Secondino S; Cinieri S; Fedele R; Bengala C; Bregni M; Grasso D; De Giorgi U; Lanza F; Castagna L; Bruno B; Martino M;
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):501-6. PubMed ID: 24374214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group.
    Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH
    N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.
    Peters WP; Dansey RD; Klein JL; Baynes RD
    Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of stem cell-supported high-dose chemotherapy in the treatment of gynecological malignancies: indications and current clinical trials in the Federal Republic of Germany].
    Nitz U; Frick M; Adomeit A; Jackisch C; Schwenkhagen A; Möbus V; Bender HG
    Zentralbl Gynakol; 1997; 119(5):195-203. PubMed ID: 9281252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.
    Rodenhuis S; Bontenbal M; Beex LV; Wagstaff J; Richel DJ; Nooij MA; Voest EE; Hupperets P; van Tinteren H; Peterse HL; TenVergert EM; de Vries EG;
    N Engl J Med; 2003 Jul; 349(1):7-16. PubMed ID: 12840087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
    Nieto Y; Cagnoni PJ; Shpall EJ; Xu X; Murphy J; Vredenburgh J; Chao NJ; Bearman SI; Jones RB
    Clin Cancer Res; 1999 Nov; 5(11):3425-31. PubMed ID: 10589754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
    Jentsch-Ullrich K; Höffken HG; Franke A
    Zentralbl Chir; 1998; 123 Suppl 5():162-4. PubMed ID: 10063605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.